Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating TC-5214 as an adjunct therapy for major depressive disorder has completed and posted results in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD) [Phase 3]
Phase 3 trial evaluating TC-5214 as adjunct therapy for major depressive disorder has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder [Phase 3]
This clinical trial update reports the results of a Phase 3 study evaluating TC-5214 as an adjunctive therapy for major depressive disorder,…
-
CLINICAL_TRIALS research · 2012-11-20Clinical Trial Update: COPD Assessment Test Can Predict Depression
This clinical trial update reports that the COPD Assessment Test may predict depressive symptoms in patients with COPD, indicating a potenti…
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: The Long-term Effects of Body-mind-spirit Group Therapy [Phase 2, Phase 3]
This clinical trial update reports on the long-term effects of body-mind-spirit group therapy in depression and sleep disorders, conducted i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Psychosocial Treatment of Depression in Parkinson's Disease [NA]
An update on a clinical trial evaluating psychosocial treatment for depression in Parkinson's disease.
-
CLINICAL_TRIALS research · 2012-11-16Clinical Trial Update: Exploring the Experience of Communication for Patients With Depression
A clinical trial update examining how patients with depression experience communication in their care. The study is sponsored by National Ta…
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Young Adult and Teen Sleep Study [Phase 2]
A Phase 2 sleep study sponsored by Kaiser Permanente in young adults and teens has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression [Phase 4]
A Phase 4 trial comparing duloxetine to placebo for binge eating disorder with depression has completed, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder [Phase 2]
Phase 2 trial evaluating erythropoietin for depressive symptoms and neurocognitive deficits in mood disorders; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults [Phase 2, Phase 3]
An update on the completed Phase 2/Phase 3 clinical trial evaluating folic acid and omega-3 fatty acid supplementation for depression in old…
-
CLINICAL_TRIALS trial_result · 2012-11-05Clinical Trial Update: Efficacy of Narrative Exposure Therapy (NET) in Treating Women After Human Trafficking or Forced Prostitution [NA]
A completed clinical trial evaluating Narrative Exposure Therapy for posttraumatic stress disorder, depression, and dissociation in women wh…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope [Phase 4]
A Phase 4 clinical trial update evaluating the effects of quetiapine XR in adults with major depressive disorder who exhibit an aberrant N10…
-
CLINICAL_TRIALS research · 2012-11-01Clinical Trial Update: Efficacy of a Program for the Management of Depression in Pregnant Women in Primary Care in São Paulo, Brazil [NA]
Clinical trial update on a program for managing depression in pregnant women in primary care in São Paulo, Brazil; the phase and current sta…
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Randomized Clinical Trial of an Exposure-based Cognitive Therapy for Depression [Phase 2]
Phase 2 randomized trial evaluating exposure-based cognitive therapy for major depressive disorder; the status of the study is unknown.
-
FDA approval · 2012-10-30FDA Approved: REMERON — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for REMERON (mirtazapine) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression [Phase 2]
Phase 2 trial investigating the combination of Naltrexone SR and Bupropion SR in overweight or obese adults with major depressive disorder h…
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder. [Phase 3]
Phase 3 study evaluating TC-5214 as an adjunct therapy for major depressive disorder has completed with results posted (October 29, 2012).
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder [Phase 3]
Phase 3 clinical trial update reporting long-term safety of TC-5214 as an adjunct therapy in patients with major depressive disorder; result…
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder. [Phase 2]
A Phase 2 trial assessing the safety and effects of TC-5214 in adults with major depressive disorder was terminated; results were posted in …
-
FDA approval · 2012-10-26FDA Approved: PAMELOR — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for PAMELOR (nortriptyline hydrochloride) submitted by SpecGx LLC.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression [Phase 4]
Phase 4 clinical trial evaluating aripiprazole augmentation of SSRI therapy in treatment-refractory major depressive disorder, with results …
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon [Phase 3]
Phase 3 trial investigating combined SSRI and ramelteon for time to remission of depressive symptoms in major depressive disorder with insom…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder [NA]
A completed clinical trial evaluating culturally based congruent care for treating Hispanics with major depressive disorder.
-
FDA approval · 2012-10-24FDA Approved: IMIPRAMINE HYDROCHLORIDE — Original Application (Leading Pharma, LLC)
The FDA approved the original ANDA for a generic imipramine hydrochloride product from Leading Pharma, LLC, enabling marketing of a generic …